Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2025-12-25 @ 3:01 AM
NCT ID:
NCT00208533
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of autism (DSM-IV) made by a boarded child and adolescent psychiatrist.
* Males and females.
* Aged 12 to 18 years.
* Clinical judgment that medication treatment for autism is indicated.
Exclusion Criteria:
* Major medical problems including cardiac, liver, endocrine, or renal diseases.
* Uncontrolled seizures.
* Baseline QTC greater than 425 msec.
* Concomitant treatment with psychotropic medication.
* History of prior exposure to aripiprazole.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Maximum Age:
18 Years
Study:
NCT00208533
Study Brief:
Protocol Section:
NCT00208533